Provided by Tiger Trade Technology Pte. Ltd.

MetaVia Inc

1.53
+0.07004.79%
Post-market: 1.530.00000.00%16:04 EDT
Volume:36.07K
Turnover:54.05K
Market Cap:10.08M
PE:-0.41
High:1.53
Open:1.44
Low:1.44
Close:1.46
52wk High:19.03
52wk Low:0.9661
Shares:6.59M
Float Shares:4.81M
Volume Ratio:0.59
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7193
EPS(LYR):-7.3500
ROE:-175.68%
ROA:-58.82%
PB:1.48
PE(LYR):-0.21

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 19

MetaVia Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

MetaVia Q2 EPS $(0.90) Misses $(0.82) Estimate

Benzinga Earnings
·
Aug 07

MetaVia Q2 FY26 Net Loss Widens to $5.3 Million

Reuters
·
Aug 07

MetaVia Inc Expected to Post a Loss of 82 Cents a Share - Earnings Preview

Reuters
·
Aug 03

Analyst Reaffirms Buy on MTVA as DA-1726 Data De-Risk Obesity and MASH Opportunity; Price Target Maintained at $20

TIPRANKS
·
Jul 10

Metavia Price Target Maintained with a $20.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 10

Metavia Says All Active Patients Reach Highest Target Doses in Da-1726 Obesity Phase 1 Part 3 Study

Reuters
·
Jul 09

Metavia - All Patients Reach Highest Target Doses of 48 Mg and 64 Mg in Phase 1 Part 3

THOMSON REUTERS
·
Jul 09

Metavia - Topline Data from Phase 1 Part 3 Expected in Q4 2026

THOMSON REUTERS
·
Jul 09

Metavia Announces Completion of Dose Titration in Phase 1 Part 3 Study of Da-1726 for the Treatment of Obesity

THOMSON REUTERS
·
Jul 09

MetaVia CEO to join Life Sciences Virtual Investor Forum fireside chat on obesity, metabolic therapies

Reuters
·
Jun 17

Analysts Offer Insights on Healthcare Companies: MetaVia (MTVA) and Adlai Nortye Ltd. Sponsored ADR (ANL)

TIPRANKS
·
Jun 09

BRIEF-Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors

Reuters
·
Jun 09

Biostem Technologies Announces Appointment of Three New Members to Its Board of Directors

THOMSON REUTERS
·
Jun 09

Metavia - Stockholders Approve Reverse Stock Split at Ratio Between 1-for-5 and 1-for-22 - SEC Filing

THOMSON REUTERS
·
Jun 09

MetaVia shareholders approved 200,000-share increase to equity incentive plan at annual meeting

Reuters
·
Jun 09

MetaVia presents data at ADA supporting DA-1726, vanoglipel

TIPRANKS
·
Jun 08

MetaVia says Phase 1 trial shows DA-1726 cuts mean body weight up to 9.1% by Day 54

Reuters
·
Jun 08

MetaVia to present at Emerging Growth Conference on obesity, metabolic therapy pipeline

Reuters
·
Jun 04